PropertyValue
?:abstract
  • • Complications such as pneumomediastinum and/or pneumothorax during the course of COVID-19 remain rare and their mechanism is poorly described. • We present a case of COVID-19 pneumonia associated with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in an immunocompetent patient with no past history of smoking or chronic obstructive pulmonary disease (COPD). • This is the first case of spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema due to COVID-19 in France. • The only risk factor of this patient was prolonged cough. • We hypothesis the mechanism underlying the pneumomediastinum is the aggressive disease pathophysiology in COVID-19 with an incresead risk of alveolar damage.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.nmni.2020.100785
?:journal
  • New_Microbes_New_Infect
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/018cb4585550b9432ac3d6a52e7111f2cf07e1d5.json
?:pmcid
?:pmid
?:pmid
  • 33072337.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema
?:type
?:year
  • 2020-10-14

Metadata

Anon_0  
expand all